4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001062993-24-001083
President and CEO acquired 66,125 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BEN-MAIMON CAROLE President and CEO | 2024-01-17 | Grant or award | +66,125 | 332,954 | D | ||
| Derivatives | |||||||
| BEN-MAIMON CAROLE President and CEO | 2024-01-17 | Grant or award · Stock Option (Right to Buy) | +396,750 | 396,750 | D | ||
Loading xslF345X05/form4.xml…